Community Contributor
Member since 2026
Views
0 Total number of views
Fair Values Set
0 Total number of fair values set
Comments
0 Total number of comments
Followers
0 Total number of followers

No bio added yet

No link added
RYTM logo
Rhythm Pharmaceuticals

High-Growth Emerging Commercial Stage Biotech

Rhythm Pharmaceuticals is a high-growth commercial-stage company targeting orphan neuroendocrine disorders linked to MC4R pathway dysfunction (genetic obesity). Having expanded from one disorder to multiple approved indications, the company has additional opportunities ahead to expand its portfolio.Read more

View narrative
US$134
13.7% undervalued intrinsic discount
Fair Value
SOTP approach. (all PoS adjusted) IMCIVREE for BBS/POMC/LEPR = $3,589 IMCIVREE for AHO = $6,440 IMCIVREE for PWS = $673 Bivamelagon = $351 RM-718 = $88 Less: PV of corp O/H = $2,341 Net SOPT Value = $8,711 Add: Cash = $331 Equity Value = $9,042 Value per Share = $134